patentlitigation.ch: Recent Episodes

Martin Wilming

Patents can be hard to swallow. Litigation even more so. Just imagine what happens when both come together. I predigest some selected case law of the Swiss courts in patent matters in this podcast. I also cover topics from the European Patent Office (EPO) that I feel might be of broader interest. Thank you for listening. Oh, and if you like this Podcast, you might also find my Blog useful: www.patentlitigation.ch

View Details

This is a recording (audio only) of the LinkedIn Live session of Wed, 25 October 2023. It covers the following topics:๐Ÿ‘‰ Pear ./. AppleO2020_014: Judgment of 2 October 2023๐Ÿ‘‰ Novartis ./. MephaO2021_004/5: Appeal dismissed by SC๐Ÿ‘‰ G1/22 and G2/22Entitlement to priority๐Ÿ‘‰ Quality at the EPOLetter of the CSC of the EPO of 16 October 2023

A video of the whole session is available here:
https://youtu.be/a9l6pz9KLDg

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is a recording of the LinkedIn Live session of Wed, 27 September 2023. It covers the following topics:

๐Ÿ‘‰ H. Lรผdi + Co. ./. Wobatech
O2021_018: Judgment of 31 August 2023

๐Ÿ‘‰ C&E Fein, Robert Bosch ./. Coram Tools
O2022_002: Hearing of 14 September 2023

๐Ÿ‘‰ VESPA evening seminar: Case-law of the Swiss FPC
14 September 2023 in Zurich, w Tobias Bremi

๐Ÿ‘‰ Election of Judges at the FPC

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is a recording of the LinkedIn Live session of Wed, 30 August 2023.

This episode covers the following:
๐Ÿ‘‰ ๐—ž๐—ผ๐—ป๐—ถ๐—ป๐—ธ๐—น๐—ถ๐—ท๐—ธ๐—ฒ ๐——๐—ผ๐˜‚๐˜„๐—ฒ ๐—˜๐—ด๐—ฏ๐—ฒ๐—ฟ๐˜๐˜€ ./. ๐——๐—ฒ๐—น๐—ถ๐—ฐ๐—ฎ
S2022_009: Judgment of 19 July 2023
https://lnkd.in/etAq8_Wh

๐Ÿ‘‰ ๐—•๐—ฎ๐˜†๐—ฒ๐—ฟ ./. ๐—”๐—ฐ๐—ถ๐—ป๐—ผ
S2023_006: Judgment of 25 July 2023
https://lnkd.in/etKaXeQR

๐Ÿ‘‰ ๐—บ๐˜†๐—ฆ๐˜๐—ฟ๐—ผ๐—บ๐—ฒ๐—ฟ ./. ๐—ฅ๐—ฒ๐˜ƒ๐—ผ๐—น๐˜ ๐—ญ๐˜†๐—ฐ๐—น๐—ถ๐—ป๐—ด
S2023_002: Order of 8 June 2023 and Judgment of 10 July 2023
Order: https://lnkd.in/ekbddbwa
Judgment: https://lnkd.in/enxXqTcw
Background information: https://lnkd.in/eEMjRa_g

๐Ÿ‘‰ ๐—ก๐—ฒ๐˜€๐˜๐—น๐—ฒฬ ./. ๐—ž-๐—ณ๐—ฒ๐—ฒ ๐—ฆ๐˜†๐˜€๐˜๐—ฒ๐—บ
O2022_003: Judgment of 2 August 2023
https://lnkd.in/ezhsUwQy

๐Ÿ‘‰ ๐—–&๐—˜ ๐—™๐—ฒ๐—ถ๐—ป, ๐—•๐—ผ๐˜€๐—ฐ๐—ต ./. ๐—–๐—ผ๐—ฟ๐—ฎ๐—บ ๐—ง๐—ผ๐—ผ๐—น๐˜€
O2022_002: Hearing of 14 September 2023
https://lnkd.in/eK_dqq6N

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is an audio recording of a LinkedIn Live session of 26 July 2023. It covers the following:
๐Ÿ‘‰ ๐—”๐—ด๐—ฟ๐—ผ ./. ๐— ๐—ผ๐—ฟ๐—ฎ๐—ฐ๐—ต-๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ถ๐—ธ
O2021_012, Judgment of 25 May 2023:
https://lnkd.in/eBdhPKYX
๐Ÿ‘‰ ๐—š๐—ฟ๐—ฒ๐˜‚๐—ฏ๐—ฒ๐—น ๐—™๐—ผ๐—ฟ๐˜€๐—ฒ๐˜† ./. ๐—ฃ๐˜‚๐—ฟ๐—ป๐—ฒ๐—น๐—น
O2021_008 / O2021_016, Hearing of 31 May 2023
๐Ÿ‘‰ ๐—จ๐—น๐˜๐—ฟ๐—ฎ๐˜€๐˜‚๐—ป ./. ๐—ฆ๐˜๐—ฎ๐—ฑ๐—ฎ
O2021_009 / O2021_010, Judgment of 6 June 2023
https://lnkd.in/eAzwFzSF
๐Ÿ‘‰ ๐—ค๐˜‚๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐—˜๐—ฃ๐—ข
Background: https://lnkd.in/esWa9fw7

A video recording is available here:

https://www.linkedin.com/video/live/urn:li:ugcPost:7089911301610582017/

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is a recording of the LinkedIn Audio event of 31 May 2023.

(The LinkedIn live session had some audio transmission issues, but this recording is fine.)

The following topics are covered in this episode:

๐Ÿ‘‰ ๐—ฆ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฏ_๐Ÿฌ๐Ÿฌ๐Ÿญ
Imholz GmbH ./. Emil Gisler AG
Order of 15 Feb 2023, Judgment of 11 Apr 2023
๐Ÿ‘‰ ๐—ข๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿญ_๐Ÿฌ๐Ÿฌ๐Ÿฐ, ๐—ข๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿญ_๐Ÿฌ๐Ÿฌ๐Ÿฑ
Mepha Pharma AG ./. Novartis AG
Judgment of 5 Apr 2023
๐Ÿ‘‰ ๐—ข๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿญ_๐Ÿฌ๐Ÿฌ๐Ÿฒ, ๐—ข๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿญ_๐Ÿฌ๐Ÿญ๐Ÿฑ
K-fee System GmbH ./. Nestlรฉ Nespresso SA
Judgment of 11 May 2023
๐Ÿ‘‰ ๐—ข๐˜‚๐˜๐—น๐—ผ๐—ผ๐—ธ: ๐—›๐—ฒ๐—ฎ๐—ฟ๐—ถ๐—ป๐—ด๐˜€ in June

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is a recording of the LinkedIn Audio event of 26 April 2023.

The following topics are covered in this episode:

๐Ÿ‘‰ S2022_010
Merck Sharp & Dohme ./. Spirig HealthCare
Order of 16 Jan 2023, Judgment of 27 March 2023
๐Ÿ‘‰ O2020_006
Rotho Kunststoff ./. Keter Plastic
Judgment of 5 April 2023
๐Ÿ‘‰ O2021_009, O2021_010
Ultrasun ./. STADA Arzneimittel
Hearing of 17 April 2023๐Ÿ‘‰ S2023_001

Imholz ./. Emil Gisler AG Maschinenbau und Hydraulik

Order of 15 February 2023, Judgment of 11 April 2023

๐Ÿ‘‰ Outlook for next month

  • Judgment of the SC re O2020_017

  • Judgment of the FPC re DoE in case of numerical ranges

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is a recording of the Fireside Chat of 29 March 2023, 12:15 hrs CEST.

(If you want to join us live next time: I am always aiming for the last Wednesday of a months, over lunch 12:15-12:45 hrs CE(S)T. I will share the invite and the draft agenda over LinkedIn; let's connect there: https://www.linkedin.com/in/mwilming/.)

The following topics are covered in this episode:

๐Ÿ‘‰ O2021_006, O2021_015
K-Fee System ./. Nestlรฉ Nespresso
News from the hearing of 22 March 2023

๐Ÿ‘‰ O2021_009, O2021_010
Ultrasun ./. STADA Arzneimittel
Forthcoming hearing of 17 April 2023

๐Ÿ‘‰ O2021_013
Flexous ./. LVMH Swiss Manufactures
Forthcoming hearing of 27 April 2023

๐Ÿ‘‰ G 2/21 (Plausibility)
Decision of 23 March 2023: Where do we go from there?

๐Ÿ‘‰ Update: The "dossier" ('Aktenheft') of a patent application; Art. 65 PatA.

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is an audio recording of the LinkedIn Live session of 1 March 2023 (I started the recording a little late, but nothing essential is missing). It covers the following topics:

๐Ÿ‘‰ S2022_007
Harry Winston ./. Creaditive et al.
Judgment of 6 January 2023

๐Ÿ‘‰ O2021_006, O2021_015
K-Fee System ./. Nestlรฉ Nespresso
State of play; forthcoming hearing of 22 March 2023

๐Ÿ‘‰ PatA revision: Yet another bug?
(No) File inspection by third parties in appeals against the grant?

๐Ÿ‘‰ The "dossier" ('Aktenheft') of a patent application; Art. 65 PatA

--- Send in a voice message: https://podcasters.spotify.com/pod/show/martin-wilming/message

View Details

This is a recording of the LinkedIn Audio session of 27 July 2022 (without the follow-up discussions with the audience). The following topics are covered:

1๏ธโƒฃ S2022_001 (register ban in entitlement proceedings)

2๏ธโƒฃ 4A_41/2022 (on appeal against O2020_002; JDE ./. Delica)

3๏ธโƒฃ 4A_11/2022 (on appeal against O2019_007; MGI ./. Illumina)

4๏ธโƒฃ Ulrich Meyer's recent guest comment in the NZZ Neue Zรผrcher Zeitung, https://lnkd.in/eKh7Dxx9


Send in a voice message: https://anchor.fm/martin-wilming/message

View Details

This is an audio recording of the LinkedIn Live session of 29 June 2022. The following topics are covered:

๐Ÿ‘‰S2022_002

Novartis ./. Mepha Pharma

Order of 2 June 2022: โ€˜Fingolimod 0.5 mgโ€™

๐Ÿ‘‰O2020_004 (the aftermath)

yodoba AG ./. Swisscom (Schweiz) AG

Rumour has it โ€ฆ

๐Ÿ‘‰INGRES

Some take-aways from the event of 23 June 2022


Send in a voice message: https://anchor.fm/martin-wilming/message

View Details

This is an audio recording of the LinkedIn Live session of 1 June 2022. It covers the following topics:

๐Ÿ‘‰S2022_001

Pelliheat AG ./. Hans SCHร„REN

Judgment of 2 March 2022: 'Register ban'

๐Ÿ‘‰O2020_004

yodoba AG ./. Swisscom (Schweiz) AG

Judgment of 22 March 2022: 'Swisscom TV 2.0'

๐Ÿ‘‰S2021_006

Bayer HealthCare LLC ./. Helvepharm AG

Judgment of 26 April 2022: 'Sorafenib tosylate'

๐Ÿ‘‰The FPC's 10th Anniversary

Symposium of 6 May 2022: A quick recap

๐Ÿ‘‰Art. 84 EPC

Claims shall ยซbe supported by the descriptionยป ...


Send in a voice message: https://anchor.fm/martin-wilming/message

View Details

Decision G 1/19 of the Enlarged Board of Appeal has been published on 10 March 2021. The decision is not only of relevance for computer-implemented simulations, but rather for all kinds of mixed inventions. G 1/19 carves the COMVIK approach (T 641/00) in stone - and stops short of saying that the former lead case in the field of computer-implemented simulation, T 1227/05 (Infineon), came to the wrong conclusion.ย 


Send in a voice message: https://anchor.fm/martin-wilming/message